Cost Effectiveness and Resource Allocation

Table 2 Utility weights used for quality-adjusted life-years in the decision tree analysis

From: Cost-effectiveness analysis of neoadjuvant versus adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer patients during initial treatment phase

	Utility weight	Time frame (months)	Source
Surgery + chemotherapy	0.81	4.87	Dendulur et al. [22] Grutters et al. [23]
≥ 3 grade AE	0.45	0.73	Dendulur et al. [22] Grutters et al. [23]
≥ 3 grade complication	0.63	0.50	Handorf et al. [25] Lugg et al. [26]
Surgery alone	0.77	0.53	Dendulur et al. [22] Grutters et al. [23]
Chemotherapy alone	1.00	0.21	Dendulur et al. [22] Grutters et al. [23]
Death	0	–	–

Back to article page

ISSN: 1478-7547

Contact us

General enquiries: journalsubmissions@springernature.com